Semaglutide is a GLP-1 agonist, Tirzepatide targets both GIP and GLP-1, and Retatrutide (still investigational at the federal level) engages triple pathways for weight and metabolic effects
Once you settle in at your maintenance dose, gastrointestinal side effects should improve and ultimately go away (although for some people, you may feel mild side effects the day after you give yourself the injection)
Figure 7 Vomiting According to the results, vomiting is more common in the treatment group (ROSE-010 at 100 g) than in the placebo group in all of the included investigations
Younce, C
Signs and symptoms of low blood sugar may include dizziness or light-headedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jittery dehydration leading to kidney problems
Gradual dose titration Work with your prescriber to titrate your GLP-1 medication slowly